The 3rd dose of their vaccine for Covid-19 can also treat the Omicron mutation, they announced with a joint announcement by Pfizer Inc. and BioNTech SE.
In their first official announcement about the effectiveness of their vaccine against Omicron, after their initial laboratory tests, BioNTech and Pfizer reported that both doses of the drug had lower production of neutralizing antibodies, however the third dose of the vaccine increased their neutralizing antibodies by 25 times.
According to a telegram by Bloomberg, The production of this amount of neutralizing antibodies is at the same level as that observed with the two doses of the formulation against the original strain of the virus and subsequent mutations.
The two companies, in their announcement, added that, if necessary, they can grant – in March 2022 – a vaccine that will specifically target the Omicron variant.
Pfizer CEO Albert Burla said: “It is clear from these preliminary data that protection improves with the third dose.” best way to prevent the transmission of COVID-19 “, he added.
For his part, BioNTech CEO Ugur Sahin noted that “initial data suggest that a third installment could offer even greater protection.”
Follow Skai.gr on Google News
and be the first to know all the news
.
